Hickey, Theresa E. http://orcid.org/0000-0002-2752-730X
Selth, Luke A.
Chia, Kee Ming
Laven-Law, Geraldine http://orcid.org/0000-0001-5326-1931
Milioli, Heloisa H. http://orcid.org/0000-0001-5104-487X
Roden, Daniel http://orcid.org/0000-0003-2393-5805
Jindal, Shalini
Hui, Mun
Finlay-Schultz, Jessica http://orcid.org/0000-0002-7855-9870
Ebrahimie, Esmaeil http://orcid.org/0000-0003-1699-3476
Birrell, Stephen N. http://orcid.org/0000-0002-1023-413X
Stelloo, Suzan
Iggo, Richard http://orcid.org/0000-0002-8822-9111
Alexandrou, Sarah http://orcid.org/0000-0003-1186-6507
Caldon, C. Elizabeth http://orcid.org/0000-0003-1392-3472
Abdel-Fatah, Tarek M.
Ellis, Ian O.
Zwart, Wilbert http://orcid.org/0000-0002-9823-7289
Palmieri, Carlo
Sartorius, Carol A.
Swarbrick, Alex http://orcid.org/0000-0002-3051-5676
Lim, Elgene http://orcid.org/0000-0001-8065-8838
Carroll, Jason S. http://orcid.org/0000-0003-3643-0080
Tilley, Wayne D. http://orcid.org/0000-0003-1893-2626
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1084416, 1130077, 1130077, 1084416, 1093801, 1084416, 1130077, 1084416, 1130077, 1130077, 1084416, 1084416, 1130077, 1130077, 1084416, 1130077, 1084416, 1084416, 1130077)
National Breast Cancer Foundation (IIRS-19-009, ECF-17-002, PS-15-041)
Cancer Australia (1107170, 1107170, 1107170, 1107170)
Hospital Research Foundation
Joint Movember & National Breast Cancer Foundation Collaboration Initiative
U.S. Department of Defense (BC103923)
Royal Adelaide Hospital
University of Adelaide
Cancer Institute NSW (ECF-17-1156)
U.S. Department of Health & Human Services | National Institutes of Health (NIHR01CA140985, NIHR01CA140985)
Breast Cancer Research Foundation
Movember Foundation (NKI01, NKI01)
KWF Kankerbestrijding (10084, 10084)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91716401, 91716401)
Cancer Research UK
Article History
Received: 20 August 2020
Accepted: 3 November 2020
First Online: 18 January 2021
Competing interests
: S.N.B. is a major shareholder in Havah Therapeutics Pty Ltd. Research support was received from AstraZeneca (W.Z.), Astellas Pharma (W.Z.) and GTx Inc. (W.D.T. and C.P.). All other authors declare no competing interests.